Pfizer (PFE)

Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.

In a development that has sent ripples of concern through financial markets, the U.S. Treasury yield curve underwent a significant un-inversion in April 2025, following its longest inversion in history, spanning from 2022 through 2024. This shift, characterized by short-term interest rates falling below long-term rates once again, initially

Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Tuesday. Discover the stocks that are generating the highest trading volume and driving market activity.

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 4% in the morning session after the company announced positive preliminary data for its updated 2025-2026 COVID-19 vaccine, Spikevax®. 

In an otherwise hot stock market, healthcare stocks are underperforming.

Moderna's updated Spikevax shows strong antibody response and safety, targeting dominant COVID-19 variants like LP.8.1 in high-risk and older adults.

Pfizer has an attractive 7.2% dividend yield, but this healthcare giant might be a riskier dividend stock than you want to own.

A good stock is an even better buy when it's on sale, even if your primary goal is immediate and reliable income.

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.

Health and Human Services Secretary Robert F. Kennedy Jr. has added five new members to the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices, just days before it reconvenes to vote on COVID-19 shots and other routine pediatric vaccine recommendations.

Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest and driving market movements.

As autumn leaves begin to fall, a familiar chill often descends upon the financial markets, not just in temperature but in investor sentiment. September has historically earned a notorious reputation among traders and analysts as the weakest month for equities, a phenomenon widely dubbed the "September Effect." This recurring statistical

The global anti-obesity drug market is experiencing an unprecedented surge, driven by groundbreaking advancements in pharmacotherapy, particularly the advent of highly effective GLP-1 receptor agonists. These revolutionary medications, capable of achieving significant weight loss, are not only transforming the treatment landscape for millions but also igniting a fierce battle among

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.

Markets closed Friday in mixed fashion as economic uncertainty and politics clashed with earnings optimism. Oracle's rollercoaster continues, RFK Jr. rattles vaccine makers, and the Fed appears poised to begin its rate-cut cycle next week. All this while tech, AI, and takeover buzz kept parts of the market energized.

Several top blue-chip stocks sport big dividend yields, but weak cash flow and sector headwinds raise questions of value trap versus smart buy.

How does $700 in annual income sound for every $10,000 in shares owned?

The type of vaccine it's most famous for might be cast in a very unflattering light in the very near future..

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 7.8% in the afternoon session after reports revealed Trump administration health officials plan to link COVID-19 vaccines to the deaths of around two dozen children. 

Shares of global pharmaceutical company Pfizer (NYSE:PFE) fell 3.5% in the afternoon session after reports revealed federal health officials are planning to link COVID-19 vaccines to the deaths of children. 

The healthcare industry is currently experiencing a transformative "golden age," a period marked by an unprecedented surge in scientific breakthroughs and technological advancements. This era is fundamentally altering the landscape of medical treatment and diagnostics, promising a future of more personalized, precise, and preventive medicine. At the forefront of this

Shares of COVID-19 vaccine makers are trading lower Friday. Vaccine stocks fell Friday on a Washington Post report that Trump administration officials plan to link the shots to 25 child deaths.

Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.